Search

Your search keyword '"Bednarski A"' showing total 2,043 results

Search Constraints

Start Over You searched for: Author "Bednarski A" Remove constraint Author: "Bednarski A" Database OpenAIRE Remove constraint Database: OpenAIRE
2,043 results on '"Bednarski A"'

Search Results

2. Pharmacokinetics and pharmacodynamics of intramuscular dexmedetomidine in dogs

3. Synthesis, characterization, and application of 2D/2D TiO2-GO-ZnFe2O4 obtained by the fluorine-free lyophilization method for solar light-driven photocatalytic degradation of ibuprofen

4. A contact tracing SIR model for randomly mixed populations

5. Do increased serum IL-12 and IL-23 levels affect cognitive function in patients with multiple sclerosis? A preliminary study

6. Structural studies and selected physical investigations of LiCoO2 obtained by combustion synthesis

7. Unsupervised learning to characterize patients with known coronary artery disease undergoing myocardial perfusion imaging

10. Evaluation of Suitability of New Bedding Material Obtained after Straw Biogasification for Dairy Cows

11. Minimum standards of pelvic exenterative practice:PelvEx Collaborative guideline

12. Event Free Survival in Severe Combined Immune Deficiency (SCID) Infants after Conditioned Umbilical Cord Blood Transplantation (UCBT) Benefits from Omitting Serotherapy

14. Magnetic Resonance Imaging Directed Surgical Decision Making for Lateral Pelvic Lymph Node Dissection in Rectal Cancer After Total Neoadjuvant Therapy (TNT)

15. Adoption of Telemedicine for Postoperative Follow-Up After Inpatient Cancer-Related Surgery

16. A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients

22. Supplementary Figure 6 from Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: A Light-Activated Antitumor Platinum Complex That Kills Human Cancer Cells by an Apoptosis-Independent Mechanism

23. Supplementary Figure 1 from Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: A Light-Activated Antitumor Platinum Complex That Kills Human Cancer Cells by an Apoptosis-Independent Mechanism

24. Supplementary Figure 3 from Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: A Light-Activated Antitumor Platinum Complex That Kills Human Cancer Cells by an Apoptosis-Independent Mechanism

26. Supplementary Figure 4 from Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: A Light-Activated Antitumor Platinum Complex That Kills Human Cancer Cells by an Apoptosis-Independent Mechanism

27. Supplementary Figure 2 from Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: A Light-Activated Antitumor Platinum Complex That Kills Human Cancer Cells by an Apoptosis-Independent Mechanism

28. Data from Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: A Light-Activated Antitumor Platinum Complex That Kills Human Cancer Cells by an Apoptosis-Independent Mechanism

29. Supplementary Figure 5 from Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: A Light-Activated Antitumor Platinum Complex That Kills Human Cancer Cells by an Apoptosis-Independent Mechanism

30. Do Rutin and Quercetin Retain Their Structure and Radical Scavenging Activity after Exposure to Radiation?

32. Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost

36. Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative

37. Modifications of the Triaminoaryl Metabophore of Flupirtine and Retigabine Aimed at Avoiding Quinone Diimine Formation

39. Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution

40. Supercapacitance in graphene oxide materials modified with tetrapyrrole dyes: a mechanistic study

42. Depression screening in chronic hemodialysis patients

43. Crack Shape Coefficient: Comparison between Different DFOS Tools Embedded for Crack Monitoring in Concrete

48. The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant

49. Evaluation of some safety parameters of dual histamine H$_{3}$ and sigma-2 receptor ligands with anti-obesity potential

50. Czy wynik CHA2DS2-VASc determinuje leczenie przeciwzakrzepowe u pacjentów z migotaniem przedsionków? Dane z POLish Atrial Fibrillation (POL-AF) Registry?

Catalog

Books, media, physical & digital resources